Dr. Frank van Leth
Home
Projects
Current
Previous
Publications
Talks
General Public
CV
Contact
Lorenzo Guglielmetti
Latest
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement
Availability and costs of medicines for the treatment of tuberculosis in Europe
Rifapentine access in Europe: growing concerns over key tuberculosis treatment component
The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation.
Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe
Cite
×